Risk factors for small bowel bacterial overgrowth in cystic fibrosis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 2, 2007, Pages 212-218

  Fridge, Jacqueline L ^a   Conrad, Carol ^b   Gerson, Lauren ^c   Castillo, Ricardo O ^b   Cox, Kenneth ^b  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bacterial overgrowth syndrome; Cystic fibrosis; Hydrogen breath test; Pancreatic insufficiency

Indexed keywords

AZITHROMYCIN; HYDROGEN; IPRATROPIUM BROMIDE; LAXATIVE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BACTERIAL FLORA; BACTERIUM; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HYDROGEN BREATH TEST; INTESTINE FLORA; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SMALL INTESTINE;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; BREATH TESTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; HYDROGEN; INTESTINAL DISEASES; INTESTINE, SMALL; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; RISK FACTORS;

BACTERIA (MICROORGANISMS);

EID: 33846589817     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31802c0ceb     Document Type: Article

References (43)

1. Hamilton JD, Dyer NH, Dawson AM, et al. Assessment and significance of bacterial overgrowth in the small bowel. Q J Med 1970;39:265-85.
2. Pignata C, Budillon G, Monaco G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut 1990;31:879-82.
3. Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994;35:23-6.
4. Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 1996; 39:54-9.
5. 2) breath test for the diagnosis of bacterial overgrowth in gastric achlorhydria. Hepatogastroenterology 1987;34:219-22.
6. Sokol RJ, Durie PR. Recommendations for management of liver and biliary tract disease in cystic fibrosis Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr 1999;28 (Suppl 1):S1-S13.
7. 51Cr-EDTA and orocecal transit time in cystic fibrosis. J Pediatr Gastroenterol Nutr 1992;14:204-7.
8. Dalzell AM, Freestone NS, Billington D, et al. Small intestinal permeability and orocaecal transit time in cystic fibrosis. Arch Dis Child 1990;65:585-8.
9. Rubinstein S, Moss R, Lewiston N. Constipation and meconium ileus equivalent in patients with cystic fibrosis. Pediatrics 1986;78:473-9.
10. Norkina O, Burnett TG, De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immunol 2004;72:6040-9.
11. Lewindon PJ, Robb TA, Moore DJ, et al. Bowel dysfunction in cystic fibrosis: importance of breath testing. J Pediatr Child Health 1998;34:79-82.
12. O'Brien S, Mulcahy H, Fenlon H, et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993;34:1137-41.
13. Karcher RE, Truding RM, Stawick LE. Using a cutoff of <10 ppm for breath hydrogen testing: a review of five years' experience. Ann Clin Lab Sci 1999;29:1-8.
14. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988;95:982-8.
15. Riordan SM, McIver CJ, Walker BM, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996;91:1795-803.
16. Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth: reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990;98: 302-9.
17. Corazza GR, Benati G, Strocchi A, et al. The possible role of breath methane measurement in detecting carbohydrate malabsorption. J Lab Clin Med 1994;124:695-700.
18. Quittner AL. Measurement of quality of life in cystic fibrosis. Curr Opin Pulm Med 1998;4:326-31.
19. Bali A, Stableforth DE, Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. BMJ 1983;287:1011-3.
20. Perman JA, Modler S. Glycoproteins as substrates for production of hydrogen and methane by colonic bacterial flora. Gastroenterology 1982;83:388-93.
21. Perman JA, Modler S, Barr RG, et al. Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology 1984;87:1358-63.
22. 2) breath test: sampling methods and the influence of dietary fibre on fasting level. Scand J Gastroenterol 1985;20:1007-13.
23. Riordan SM, McIver CJ, Bolin TD, et al. Fasting breath hydrogen concentrations in gastric and small-intestinal bacterial overgrowth. Scand J Gastroenterol 1995;30:252-7.
24. Gregory PC. Gastrointestinal pH, motility/transit and permeability in cystic fibrosis. J Pediatr Gastroenterol Nutr 1996;23:513-23.
25. 2 breath tests to study extent and site of starch digestion in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1999;29:327-31.
26. Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002;97:1113-26.
27. Perman JA, Modler S, Olson AC. Role of pH in production of hydrogen from carbohydrates by colonic bacterial flora: studies in vivo and in vitro. J Clin Invest 1981;67:643-50.
28. Vogelsang H, Ferenci P, Frotz S, et al. Acidic colonic microclimate: possible reason for false negative hydrogen breath tests. Gut 1988;29:21-6.
29. Gilbert J, Kelleher J, Littlewood JM, et al. Ileal pH in cystic fibrosis. Scand J Gastroenterol Suppl 1988;143:132-4.
30. Barraclough M, Taylor CJ. Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption. J Pediatr Gastroenterol Nutr 1996;23:45-50.
31. Frase LL, Strickland AD, Kachel GW, et al. Enhanced glucose absorption in the jejunum of patients with cystic fibrosis. Gastroenterology 1985;88:478-84.
32. Baxter P, Goldhill J, Hardcastle J, et al. Enhanced intestinal glucose and alanine transport in cystic fibrosis. Gut 1990;31:817-20.
33. Laubitz D, Zabielski R, Wolinski J, et al. Physiological and chemical characteristics of antibacterial activity of pancreatic juice. J Physiol Pharmacol 2003;54:283-90.
34. Rubinstein E, Mark Z, Haspel J, et al. Antibacterial activity of the pancreatic fluid. Gastroenterology 1985;88:927-32.
35. Marotta F, Tajiri H, Li ZL, et al. Pure pancreatic juice from patients with chronic pancreatitis has an impaired antibacterial activity. Int J Pancreatol 1997;22:215-20.
36. Runkel N, Moody FG, Miller TA, et al. Promotion of bacterial translocation by altered biliary and pancreatic secretions. Gastroenterology 1994;106:A763.
37. Sherman P, Fleming N, Forstner J, et al. Bacteria and the mucus blanket in experimental small bowel bacterial overgrowth. Am J Pathol 1987;126:527-34.
38. Lichtman SN, Keku J, Clark RL, et al. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 1991;13:766-72.
39. Lichtman SN, Sartor RB. Hepatobiliary injury associated with experimental small-bowel bacterial overgrowth in rats. Immunol Res 1991;10:528-31.
40. Lichtman SN, Keku J, Schwab JH, et al. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 1991;100:513-9.
41. Smyth RL, Croft NM, O'Hea U, et al. Intestinal inflammation in cystic fibrosis. Arch Dis Child 2000;82:394-9.
42. Furuya S, Naruse S, Hayakawa T. Intravenous injection of guanylin induces mucus secretion from goblet cells in rat duodenal crypts. Anat Embryol (Berl) 1998;197:359-67.
43. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005;51 (Suppl 1):1-22.